Somatostatin receptor 1,2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo; analysis of the intracellular pathways involved

M. Gatti; A. Pattarozzi; R. Würth; F. Angeletti; F. Barbieri; T. Florio

doi:10.4081/jbr.2011.4649

Somatostatin receptor 1,2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo; analysis of the intracellular pathways involved

https://doi.org/10.4081/jbr.2011.4649

PDF

Vol. 84 No. 1 (2011)

Submitted: August 1, 2014
Accepted: August 1, 2014

Published: January 31, 2011

somatostatin, somatostatine receptor, gliomas

Abstract Views: 693

PDF: 558

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We report that somatostain receptor (SSTR) 1,2 and 5 activation by selective agonista, cause C6 cell growth arrest through PTPn-dependent dephosphorylation of ERK1/2 in vitro and after xenografting in nude mice. Individual SSTR agonist desplayed different efficacy and potecy showing partial synergism by combined treatment. Since most tumor cells express multiple SSTRs, the activtion of all the subtypes may grant a better control of cancer growth.

Gatti, M., Pattarozzi, A., Würth, R., Angeletti, F., Barbieri, F., & Florio, T. (2011). Somatostatin receptor 1,2 and 5 activation leads to C6 glioma growth arrest in vitro and in vivo; analysis of the intracellular pathways involved. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 84(1). https://doi.org/10.4081/jbr.2011.4649